MS

Meryl Stanley Parekkat

Director DIN 01638246
DIN 01638246 First appointment Jan 2005
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2005
Shareholding value β€’β€’β€’β€’ Premium profile

About Meryl Stanley Parekkat

Data last updated:

Meryl Stanley Parekkat was a Director at Mediz Medical Equipment Supplies Private Limited (from 2010) and Director at Mavely Printers Private Limited (from 2005).

DIN 01638246
First Appointment 27 Jan 2005
Oldest Company Age 21 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Sep 20102010Strike Off
Mavely Printers Private Limited U22219KL2005PTC017838
Director27 Jan 20052005Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mediz Medical Equipment Supplies Private Limited
Mavely Printers Private Limited
Premium access

Shareholding and investment profile for Meryl Stanley Parekkat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meryl Stanley Parekkat

Meryl Stanley Parekkat was first appointed on 27 Jan 2005 as Director at Mavely Printers Private Limited. The most recent appointment on record is 30 Sep 2010 at Mediz Medical Equipment Supplies Private Limited.

Meryl Stanley Parekkat held 2 earlier board appointments: Mediz Medical Equipment Supplies Private Limited (Director, from 30 Sep 2010); Mavely Printers Private Limited (Director, from 27 Jan 2005).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available